Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Nuclease Therapies
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Discovery
Recipient : Arbor Biotechnologies, Inc
Deal Size : $215.0 million
Deal Type : Series B Financing
Details : Arbor plans to use the proceeds to advance its lead programs in liver and CNS disease into the clinic and progress a pipeline of precision editing therapeutics, while continuing to invest in its novel discovery engine to develop the next generation of ge...
Brand Name : Undisclosed
Molecule Type : Large molecule
Upfront Cash : Undisclosed
November 09, 2021
Lead Product(s) : Nuclease Therapies
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Discovery
Recipient : Arbor Biotechnologies, Inc
Deal Size : $215.0 million
Deal Type : Series B Financing
LOOKING FOR A SUPPLIER?
Reset All
